KMT2A mutations occur in 5% of ALL cases, resulting in mixed-lineage leukemia rearrangement (MLL-r), cases of which exhibit worse outcomes than non-MLL cases [108,109]. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.